Encycle Therapeutics raises $2.1 mln
Encycle Therapeutics Inc. said Wednesday it raised C$2.85 million (US$2.1 million) in financing led by Takeda Pharmaceutical Company Ltd. through its venture capital arm, Takeda Ventures Inc. Also participating were Accel-Rx Health Sciences Accelerator, BDC Capital and MaRS Investment Accelerator Fund. Encycle, a University of Toronto spin-off, is a drug discovery company.
1 October 2015•3 mins read
